Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Veracity Clinical Research | Researchclopedia

Back to institutions

Veracity Clinical Research

Woolloongabba, Queenslandfacility

90

Works

4,963

Citations

20

h-index

Top Research Topics

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Cytokine Signaling Pathways and Interactions

Top Researchers

Neil J. Korman University Hospitals of Cleveland

244 works19,665 citationsh-index: 62

Recent Research

Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis

April W. Armstrong,Richard B. Warren,et al.

20250 citations

Asthma and respiratory diseases

Pharmaceutical studies and practices

Autoimmune Bullous Skin Diseases

Health Systems, Economic Evaluations, Quality of Life

Food Allergy and Anaphylaxis Research

Allergic Rhinitis and Sensitization

Nonmelanoma Skin Cancer Studies

Synthesis and biological activity

Urticaria and Related Conditions

Peter Foley The University of Melbourne

298 works11,725 citationsh-index: 50

Lynda Spelman Queensland Children’s Medical Research Institute

131 works6,086 citationsh-index: 27

Ruby Lee The University of Queensland

69 works1,588 citationsh-index: 18

Paul J. Turinsky North Carolina State University

121 works916 citationsh-index: 15

Casey Rowe The University of Queensland

27 works431 citationsh-index: 8

PCR32 Bimekizumab Improves Work Productivity in Patients With Hidradenitis Suppurativa: 2-Year Results From BE HEARD EXT

Sylke Schneider‐Burrus,Elena Sotiriou,et al.

20250 citations

60412 Safety and efficacy of topical zabalafin as a uniquely singular approach to comprehensive and effective AD management and with or without concurrent Staphylococcus aureus (SA) or MRSA infection

Lynda Spelman,Michael Benson,et al.

20250 citations

Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

Emma Guttman‐Yassky,Stephan Weidinger,et al.

20253 citations

ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis

Emma Guttman‐Yassky,Eric L. Simpson,et al.

202510 citations

Long-Term Efficacy and Safety of Lebrikizumab Is Maintained in Patients With Moderate-to-Severe Atopic Dermatitis: Results Up to 3 Years From ADjoin

Emma Guttman‐Yassky,Alan D. Irvine,et al.

20251 citations